Deccan Health Care Reports Stable Sales Amid Declining Earnings in May 2025 Results

May 29 2025 06:38 PM IST
share
Share Via
Deccan Health Care has reported its financial results for the quarter ending March 2025, highlighting stable overall performance. The company achieved its highest quarterly net sales in five quarters at Rs 20.75 crore, while earnings per share (EPS) fell to Rs 0.05, indicating challenges in profitability.
Deccan Health Care, a microcap company in the healthcare services industry, has recently reported its financial results for the quarter ending March 2025. The results, declared on May 29, 2025, indicate a stable performance in terms of overall financial metrics, with the score remaining unchanged over the past three months.

The financial data reveals that Deccan Health Care achieved its highest quarterly net sales in the last five quarters, reaching Rs 20.75 crore. This positive trend in sales suggests a favorable near-term outlook for revenue generation. However, the company is facing challenges as its earnings per share (EPS) for the same quarter dropped to Rs 0.05, marking the lowest level in the past five quarters. This decline in EPS points to a reduction in profitability, indicating that the company has generated lower earnings for its shareholders.

In light of these developments, Deccan Health Care has experienced evaluation changes that reflect the current financial landscape.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News